Testing for serum tumor biomarkers, such as carcinoembryonic antigen (CEA), carbohydrate-containing protein antigen or cancer antigen 15-3 (CA15-3), CA125, and CA199, have also been adopted for BC screening (5). The gene discussed is CEACAM5; the disease is breast cancer.